| Year |
Citation |
Score |
| 2023 |
Bonomi S, Lu R, Schindler SE, Bui Q, Lah JJ, Wolk D, Gleason CE, Sperling R, Roberson ED, Levey AI, Shaw L, Van Hulle C, Benzinger T, Adams M, Manzanares C, ... ... Grant EA, et al. Relationships of Cognitive Measures with Cerebrospinal Fluid but not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals. Annals of Neurology. PMID 38038976 DOI: 10.1002/ana.26838 |
0.377 |
|
| 2023 |
Luo J, Ma Y, Agboola FJ, Grant E, Morris JC, McDade E, Fagan AM, Benzinger TLS, Hassenstab J, Bateman RJ, Perrin RJ, Gordon BA, Goyal M, Strain JF, Yakushev I, et al. Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Lifespan. Neurology. PMID 37202169 DOI: 10.1212/WNL.0000000000207378 |
0.389 |
|
| 2023 |
Xiong C, McCue LM, Buckles V, Grant E, Agboola F, Coble D, Bateman RJ, Fagan AM, Benzinger TLS, Hassenstab J, Schindler SE, McDade E, Moulder K, Gordon BA, Cruchaga C, et al. Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36640138 DOI: 10.1002/alz.12912 |
0.457 |
|
| 2022 |
Luo J, Agboola F, Grant E, Morris JC, Masters CL, Albert MS, Johnson SC, McDade EM, Fagan AM, Benzinger TLS, Hassenstab J, Bateman RJ, Perrin RJ, Wang G, Li Y, et al. Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan. Brain : a Journal of Neurology. PMID 35925685 DOI: 10.1093/brain/awac238 |
0.474 |
|
| 2022 |
Long JM, Coble DW, Xiong C, Schindler SE, Perrin RJ, Gordon BA, Benzinger TLS, Grant E, Fagan AM, Harari O, Cruchaga C, Holtzman DM, Morris JC. Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes. Brain : a Journal of Neurology. PMID 35867858 DOI: 10.1093/brain/awac250 |
0.524 |
|
| 2022 |
Keleman AA, Bollinger RM, Wisch JK, Grant EA, Benzinger TL, Ances BM, Stark SL. Assessment of Instrumental Activities of Daily Living in Preclinical Alzheimer Disease. Otjr : Occupation, Participation and Health. 15394492221100701. PMID 35708011 DOI: 10.1177/15394492221100701 |
0.418 |
|
| 2022 |
Xiong C, Luo J, Schindler SE, Fagan AM, Benzinger T, Hassenstab J, Balls-Berry JE, Agboola F, Grant E, Moulder KL, Morris JC. Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35218143 DOI: 10.1002/alz.12608 |
0.43 |
|
| 2022 |
Xiong C, Luo J, Agboola F, Grant E, Morris JC. A family of estimators to diagnostic accuracy when candidate tests are subject to detection limits-Application to diagnosing early stage Alzheimer disease. Statistical Methods in Medical Research. 9622802211072511. PMID 35044258 DOI: 10.1177/09622802211072511 |
0.337 |
|
| 2020 |
Luo J, Agboola F, Grant E, Masters CL, Albert MS, Johnson SC, McDade EM, Vöglein J, Fagan AM, Benzinger T, Massoumzadeh P, Hassenstab J, Bateman RJ, Morris JC, Perrin RJ, et al. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study. Neurology. PMID 32873693 DOI: 10.1212/Wnl.0000000000010747 |
0.561 |
|
| 2020 |
Keleman A, Wisch JK, Bollinger RM, Grant EA, Benzinger TL, Morris JC, Ances BM, Stark SL. Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32741815 DOI: 10.3233/Jad-200192 |
0.484 |
|
| 2020 |
Wisch JK, Meeker KL, Gordon BA, Flores S, Dincer A, Grant EA, Benzinger TL, Morris JC, Ances BM. Sex-related Differences in Tau Positron Emission Tomography (PET) and the Effects of Hormone Therapy (HT). Alzheimer Disease and Associated Disorders. PMID 32520734 DOI: 10.1097/Wad.0000000000000393 |
0.356 |
|
| 2019 |
Bos I, Vos SJB, Schindler SE, Hassenstab J, Xiong C, Grant E, Verhey F, Morris JC, Visser PJ, Fagan AM. Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31378575 DOI: 10.1016/J.Jalz.2019.04.015 |
0.529 |
|
| 2019 |
Morris JC, Schindler SE, McCue LM, Moulder KL, Benzinger TLS, Cruchaga C, Fagan AM, Grant E, Gordon BA, Holtzman DM, Xiong C. Assessment of Racial Disparities in Biomarkers for Alzheimer Disease. Jama Neurology. PMID 30615028 DOI: 10.1001/Jamaneurol.2018.4249 |
0.435 |
|
| 2018 |
Roe CM, Ances BM, Head D, Babulal GM, Stout SH, Grant EA, Hassenstab J, Xiong C, Holtzman DM, Benzinger TLS, Schindler SE, Fagan AM, Morris JC. Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers. Brain : a Journal of Neurology. PMID 30304397 DOI: 10.1093/Brain/Awy244 |
0.502 |
|
| 2018 |
Stout SH, Babulal GM, Ma C, Carr DB, Head DM, Grant EA, Williams MM, Holtzman DM, Fagan AM, Morris JC, Roe CM. Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29328928 DOI: 10.1016/J.Jalz.2017.11.011 |
0.488 |
|
| 2017 |
Roe CM, Babulal GM, Head DM, Stout SH, Vernon EK, Ghoshal N, Garland B, Barco PP, Williams MM, Johnson A, Fierberg R, Fague MS, Xiong C, Mormino E, Grant EA, et al. Preclinical Alzheimer's disease and longitudinal driving decline. Alzheimer's & Dementia (New York, N. Y.). 3: 74-82. PMID 28435853 DOI: 10.1016/J.Trci.2016.11.006 |
0.474 |
|
| 2017 |
Day GS, Lim TS, Hassenstab J, Goate AM, Grant EA, Roe CM, Cairns NJ, Morris JC. Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease. Neurology. PMID 28235814 DOI: 10.1212/Wnl.0000000000003770 |
0.59 |
|
| 2017 |
Roe CM, Benzinger TLS, Fagan AM, Head DM, Ances B, Babulal GM, Stout SH, Grant EA, Holtzman DM, Morris JC. Prediction Of Incident Dementia: Longitudinal Biomarker And Clinical Changes Before And After Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.624 |
0.388 |
|
| 2017 |
Bos I, Vos SJ, Hassenstab J, Xiong C, Grant EA, Visser PJ, Morris JC, Fagan AM. ASSOCIATIONS BETWEEN VASCULAR RISK FACTORS AND AD BIOMARKERS IN COGNITIVELY NORMAL INDIVIDUALS Alzheimer's & Dementia. 13: P1506-P1507. DOI: 10.1016/J.Jalz.2017.07.621 |
0.484 |
|
| 2017 |
Xiong C, McCue L, Grant EA, Bateman RJ, Fagan AM, Benzinger TL, Hassenstab J, Buckles V, Moulder KL, Paumier KL, Morris JC. CROSS-SECTIONAL AND LONGITUDINAL COMPARISONS OF COGNITION AND BIOMARKERS AMONG COGNITIVELY NORMAL INDIVIDUALS AGED 42 TO 65 YEARS WITH A FAMILY HISTORY OF EITHER AUTOSOMAL DOMINANT AD (ADAD) OR LATE-ONSET AD (LOAD) Alzheimer's & Dementia. 13: P923. DOI: 10.1016/J.Jalz.2017.07.357 |
0.534 |
|
| 2017 |
Morris JC, Benzinger TL, Buckles VD, Fagan AM, Gordon BA, Grant EA, McCue L, Moulder KL, Schindler SE, Xiong C. RACIAL DIFFERENCES AND SIMILARITIES IN MOLECULAR BIOMARKERS FOR AD Alzheimer's & Dementia. 13: P560-P561. DOI: 10.1016/J.Jalz.2017.07.168 |
0.387 |
|
| 2017 |
Stout SH, Babulal GM, Ma C, Carr DB, Head DM, Grant EA, Williams MM, Holtzman DM, Fagan AM, Morris JC, Roe CM. Driving Cessation Over A 22-Year Period: Dementia Severity And Csf Biomarkers Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1811 |
0.401 |
|
| 2016 |
Hassenstab J, Chasse R, Grabow P, Benzinger TL, Fagan AM, Xiong C, Jasielec M, Grant E, Morris JC. Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning. Neurobiology of Aging. 43: 23-33. PMID 27255812 DOI: 10.1016/J.Neurobiolaging.2016.03.014 |
0.576 |
|
| 2016 |
Roe CM, Barco PP, Head DM, Ghoshal N, Selsor N, Babulal GM, Fierberg R, Vernon EK, Shulman N, Johnson A, Fague S, Xiong C, Grant EA, Campbell A, Ott BR, et al. Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals. Alzheimer Disease and Associated Disorders. PMID 27128959 DOI: 10.1097/Wad.0000000000000154 |
0.554 |
|
| 2016 |
Ingber AP, Hassenstab J, Fagan AM, Benzinger TL, Grant EA, Holtzman DM, Morris JC, Roe CM. Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27104893 DOI: 10.3233/Jad-150478 |
0.55 |
|
| 2016 |
Xiong C, Jasielec MS, Weng H, Fagan AM, Benzinger TL, Head D, Hassenstab J, Grant E, Sutphen CL, Buckles V, Moulder KL, Morris JC. Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study. Neurology. PMID 27009258 DOI: 10.1212/Wnl.0000000000002593 |
0.487 |
|
| 2016 |
Sheinerman KS, Tsivinsky VG, Toledo JB, McBride J, Grant EA, Fagan AM, Trojanowski JQ, Umansky SR. 05-05-06: Circulating Brain-Enriched Micrornas as Biomarkers for Early Detection And Differential Diagnosis of Alzheimer's Disease Alzheimer's & Dementia. 12: P389-P390. DOI: 10.1016/J.Jalz.2016.06.734 |
0.39 |
|
| 2016 |
Roe CM, Head DM, Babulal GM, Stout SH, Ghoshal N, Vernon EK, Selsor N, Fierberg R, Shulman N, Johnson A, Fague MS, Xiong C, Grant EA, Campbell A, Holtzman DM, et al. P4-150: Preclinical Alzheimer’s Disease Predicts Longitudinal Onset of Driving Difficulties Among Cognitively Normal Persons Alzheimer's & Dementia. 12: P1071-P1071. DOI: 10.1016/J.Jalz.2016.06.2215 |
0.479 |
|
| 2015 |
Hassenstab J, Ruvolo D, Jasielec M, Xiong C, Grant E, Morris JC. Absence of Practice Effects in Preclinical Alzheimer's Disease. Neuropsychology. PMID 26011114 DOI: 10.1037/Neu0000208 |
0.525 |
|
| 2015 |
Roe CM, Barco PP, Head DM, Ghoshal N, Selsor N, Babulal GM, Fierberg R, Vernon EK, Shulman N, Johnson A, Fague MS, Xiong C, Grant E, Campbell A, Holtzman DM, et al. P2-130: Amyloid imaging and cerebrospinal fluid biomarkers predict driving performance in preclinical Alzheimer's disease Alzheimer's & Dementia. 11: P533-P534. DOI: 10.1016/J.Jalz.2015.06.668 |
0.415 |
|
| 2015 |
Day GS, Lim TS, Hassenstab J, Grant EA, Goate A, Morris JC, Cairns NJ. Differentiating corticobasal degeneration and Alzheimer disease by longitudinal clinical and cognitive features Alzheimers & Dementia. 11: 525. DOI: 10.1016/J.Jalz.2015.06.646 |
0.524 |
|
| 2015 |
Xiong C, Jasielec MS, Fagan AM, Benzinger TL, Head DM, Hassenstab J, Grant E, Buckles V, Moulder KL, Morris JC. P1-106: Longitudinal biomarker connectivity on middle-aged asymptomatic individuals and optimal design on prevention trials of Alzheimer's disease Alzheimer's & Dementia. 11: P379-P379. DOI: 10.1016/J.Jalz.2015.06.304 |
0.418 |
|
| 2015 |
Fleisher M, Jilakara B, Grant E, Morris JC, Snider BJ. P1-098: Utility and impact of cerebrospinal fluid studies on dementia diagnosis in a specialty dementia practice Alzheimer's & Dementia. 11: P376-P376. DOI: 10.1016/J.Jalz.2015.06.295 |
0.428 |
|
| 2014 |
Pizzie R, Hindman H, Roe CM, Head D, Grant E, Morris JC, Hassenstab JJ. Physical activity and cognitive trajectories in cognitively normal adults: the adult children study. Alzheimer Disease and Associated Disorders. 28: 50-7. PMID 23739296 DOI: 10.1097/Wad.0B013E31829628D4 |
0.472 |
|
| 2013 |
Roe CM, Fagan AM, Grant EA, Holtzman DM, Morris JC. CSF biomarkers of Alzheimer disease: "noncognitive" outcomes. Neurology. 81: 2028-31. PMID 24212387 DOI: 10.1212/01.Wnl.0000436940.78152.05 |
0.551 |
|
| 2013 |
Vos SJ, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, Cairns NJ, Morris JC, Holtzman DM, Fagan AM. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. The Lancet. Neurology. 12: 957-65. PMID 24012374 DOI: 10.1016/S1474-4422(13)70194-7 |
0.568 |
|
| 2013 |
Stark SL, Roe CM, Grant EA, Hollingsworth H, Benzinger TL, Fagan AM, Buckles VD, Morris JC. Preclinical Alzheimer disease and risk of falls. Neurology. 81: 437-43. PMID 23803314 DOI: 10.1212/Wnl.0B013E31829D8599 |
0.515 |
|
| 2013 |
Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, Sutphen CL, Benzinger TL, Mintun MA, Holtzman DM, Morris JC. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology. 80: 1784-91. PMID 23576620 DOI: 10.1212/Wnl.0B013E3182918Ca6 |
0.56 |
|
| 2013 |
Ruvolo D, Chasse R, Dreyfus DM, Vernon E, Grant E, Morris J, Hassenstab J. Attenuation of practice effects on neuropsychological performance is a potential marker of preclinical Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.08.222 |
0.448 |
|
| 2013 |
Chasse R, Benzinger T, Grant E, Cairns N, Fagan A, Morris J, Hassenstab J. Alzheimer's disease biomarkers and normative cognitive data: The SuperNorms approach Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.08.220 |
0.53 |
|
| 2013 |
Vos S, Xiong C, Grant E, Visser PJ, Cairns N, Morris J, Holtzman D, Fagan A. O4-02-03: Using cerebrospinal fluid markers to identify stages of National Institute on Aging and Alzheimer's Association proposed criteria for preclinical Alzheimer's disease and its prognosis Alzheimer's & Dementia. 9: P682-P682. DOI: 10.1016/J.Jalz.2013.04.342 |
0.439 |
|
| 2012 |
Pizzie R, Hindman H, Roe C, Head D, Grant E, Morris J, Hassenstab J. Physical Activity and Cognitive Trajectories in Cognitively Normal Middle-Aged and Elderly Adults: Longitudinal Findings from the Adult Children Study (S24.002) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S24.002 |
0.493 |
|
| 2011 |
Xiong C, Roe CM, Buckles V, Fagan A, Holtzman D, Balota D, Duchek J, Storandt M, Mintun M, Grant E, Snyder AZ, Head D, Benzinger TL, Mettenburg J, Csernansky J, et al. Role of family history for Alzheimer biomarker abnormalities in the adult children study. Archives of Neurology. 68: 1313-9. PMID 21987546 DOI: 10.1001/Archneurol.2011.208 |
0.653 |
|
| 2011 |
Roe CM, Fagan AM, Grant EA, Marcus DS, Benzinger TL, Mintun MA, Holtzman DM, Morris JC. Cerebrospinal fluid biomarkers, education, brain volume, and future cognition. Archives of Neurology. 68: 1145-51. PMID 21911695 DOI: 10.1001/archneurol.2011.192 |
0.493 |
|
| 2011 |
Roe CM, Fagan AM, Williams MM, Ghoshal N, Aeschleman M, Grant EA, Marcus DS, Mintun MA, Holtzman DM, Morris JC. Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease. Neurology. 76: 501-10. PMID 21228296 DOI: 10.1212/Wnl.0B013E31820Af900 |
0.423 |
|
| 2011 |
Taylor-Reinwald L, Grant E, Goate A, Morris J, Cairns N. Neuropathology of preclinical and incipient Alzheimer's dementia Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.881 |
0.52 |
|
| 2010 |
Roe CM, Mintun MA, Ghoshal N, Williams MM, Grant EA, Marcus DS, Morris JC. Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept. Neurology. 75: 42-8. PMID 20603484 DOI: 10.1212/Wnl.0B013E3181E620F4 |
0.557 |
|
| 2010 |
Snider BJ, Pizzie RG, Roe CM, Grant EA, Fagan AM, Holtzman DM, Morris JC. P4-149: Accuracy of Clinical Diagnosis of Dementia of the Alzheimer Type: Impact of Longitudinal Follow-up and Inclusion of CSF Biomarkers Alzheimer's & Dementia. 6: e67-e67. DOI: 10.1016/J.Jalz.2010.08.208 |
0.461 |
|
| 2010 |
Taylor-Reinwald L, Grant E, Morris JC, Cairns NJ. TDP-43 proteinopathy in cognitively normal (CDR 0) individuals Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.252 |
0.456 |
|
| 2010 |
Craig-Schapiro R, Perrin RJ, Roe CM, Grant EA, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D'Angelo G, Malone JP, Townsend RR, et al. P3-190: A novel diagnostic and prognostic fluid biomarker for early Alzheimer's disease: YKL-40 Alzheimer's & Dementia. 6: S506-S506. DOI: 10.1016/J.Jalz.2010.05.1688 |
0.415 |
|
| 2009 |
Croston J, Meuser TM, Berg-Weger M, Grant EA, Carr DB. Driving Retirement in Older Adults with Dementia. Topics in Geriatric Rehabilitation. 25: 154-162. PMID 20161565 DOI: 10.1097/Tgr.0B013E3181A103Fd |
0.402 |
|
| 2009 |
Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, Fagan AM, Holtzman DM, Mintun MA. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Archives of Neurology. 66: 1469-75. PMID 20008650 DOI: 10.1001/Archneurol.2009.269 |
0.73 |
|
| 2009 |
Avidan MS, Searleman AC, Storandt M, Barnett K, Vannucci A, Saager L, Xiong C, Grant EA, Kaiser D, Morris JC, Evers AS. Long-term cognitive decline in older subjects was not attributable to noncardiac surgery or major illness. Anesthesiology. 111: 964-70. PMID 19786858 DOI: 10.1097/Aln.0B013E3181Bc9719 |
0.659 |
|
| 2009 |
Snider BJ, Fagan AM, Roe C, Shah AR, Grant EA, Xiong C, Morris JC, Holtzman DM. Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type. Archives of Neurology. 66: 638-45. PMID 19433664 DOI: 10.1001/Archneurol.2009.55 |
0.513 |
|
| 2008 |
Roe CM, Mintun MA, D'Angelo G, Xiong C, Grant EA, Morris JC. Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Archives of Neurology. 65: 1467-71. PMID 19001165 DOI: 10.1001/Archneur.65.11.1467 |
0.443 |
|
| 2008 |
Roe CM, Xiong C, Grant E, Miller JP, Morris JC. Education and reported onset of symptoms among individuals with Alzheimer disease. Archives of Neurology. 65: 108-11. PMID 18195147 DOI: 10.1001/Archneurol.2007.11 |
0.399 |
|
| 2008 |
Taylor-Reinwald L, Carter D, Felton A, Grant E, Morris JC, Cairns NJ. P4-159: Postmortem neuropathologic assessment of Aβ-deposition in the precuneus of cognitively normal individuals Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2226 |
0.476 |
|
| 2008 |
Snider BJ, Fagan AM, Roe CM, Shah AR, Grant EA, Morris JC, Holtzman DM. P3-095: Levels of CSF biomarkers predict rate of cognitive decline in individuals with very mild dementia of the Alzheimer's type Alzheimer's & Dementia. 4: T546-T546. DOI: 10.1016/J.Jalz.2008.05.1659 |
0.542 |
|
| 2006 |
Storandt M, Grant EA, Miller JP, Morris JC. Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology. 67: 467-73. PMID 16894109 DOI: 10.1212/01.Wnl.0000228231.26111.6E |
0.671 |
|
| 2006 |
Wilkins CH, Grant EA, Schmitt SE, McKeel DW, Morris JC. The neuropathology of Alzheimer disease in African American and white individuals. Archives of Neurology. 63: 87-90. PMID 16401740 DOI: 10.1001/Archneur.63.1.87 |
0.425 |
|
| 2006 |
LaMontagne PJ, Keefe S, Lauren W, Xiong C, Grant EA, Moulder KL, Morris JC, Benzinger TL, Marcus DS. P3-083: OASIS-3: LONGITUDINAL NEUROIMAGING, CLINICAL, AND COGNITIVE DATASET FOR NORMAL AGING AND ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1097-P1097. DOI: 10.1016/J.Jalz.2018.06.1439 |
0.564 |
|
| 2006 |
Storandt M, Grant EA, Miller JP, Morris JC. P2-089: Progression in mild cognitive impairment (MCI) and preMCI Alzheimer's & Dementia. 2: S259-S259. DOI: 10.1016/J.Jalz.2006.05.926 |
0.668 |
|
| 2005 |
Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E, Miller JP, Storandt M, Morris JC. The AD8: a brief informant interview to detect dementia. Neurology. 65: 559-64. PMID 16116116 DOI: 10.1212/01.Wnl.0000172958.95282.2A |
0.709 |
|
| 2005 |
Galvin JE, Powlishta KK, Wilkins K, McKeel DW, Xiong C, Grant E, Storandt M, Morris JC. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Archives of Neurology. 62: 758-65. PMID 15883263 DOI: 10.1001/Archneur.62.5.758 |
0.736 |
|
| 2005 |
Kilada S, Gamaldo A, Grant EA, Moghekar A, Morris JC, O'Brien RJ. Brief screening tests for the diagnosis of dementia: Comparison with the Mini-Mental State Exam Alzheimer Disease and Associated Disorders. 19: 8-16. PMID 15764865 DOI: 10.1097/01.Wad.0000155381.01350.Bf |
0.421 |
|
| 2004 |
McKeel DW, Price JL, Miller JP, Grant EA, Xiong C, Berg L, Morris JC. Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer type. Journal of Neuropathology and Experimental Neurology. 63: 1028-37. PMID 15535130 DOI: 10.1093/Jnen/63.10.1028 |
0.523 |
|
| 2004 |
Powlishta KK, Storandt M, Mandernach TA, Hogan E, Grant EA, Morris JC. Absence of effect of depression on cognitive performance in early-stage Alzheimer disease. Archives of Neurology. 61: 1265-8. PMID 15313845 DOI: 10.1001/Archneur.61.8.1265 |
0.675 |
|
| 2004 |
Storandt M, Powlishta KK, Mandenach TA, Hogan E, Grant EA, Morris JC. P1-073 Depression in the early stages of Alzheimer's disease does not affect psychometric test performance Neurobiology of Aging. 25: S116. DOI: 10.1016/S0197-4580(04)80387-7 |
0.617 |
|
| 2003 |
Villareal DT, Grant E, Miller JP, Storandt M, McKeel DW, Morris JC. Clinical outcomes of possible versus probable Alzheimer's disease. Neurology. 61: 661-7. PMID 12963758 DOI: 10.1212/Wnl.61.5.661 |
0.667 |
|
| 2003 |
Cacchione PZ, Powlishta KK, Grant EA, Buckles VD, Morris JC. Accuracy of collateral source reports in very mild to mild dementia of the Alzheimer type. Journal of the American Geriatrics Society. 51: 819-23. PMID 12757569 DOI: 10.1046/J.1365-2389.2003.51263.X |
0.444 |
|
| 2002 |
Storandt M, Grant EA, Miller JP, Morris JC. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology. 59: 1034-41. PMID 12370458 DOI: 10.1212/Wnl.59.7.1034 |
0.701 |
|
| 2001 |
Goldman WP, Price JL, Storandt M, Grant EA, McKeel DW, Rubin EH, Morris JC. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology. 56: 361-7. PMID 11171902 DOI: 10.1212/Wnl.56.3.361 |
0.704 |
|
| 1998 |
Hellman NE, Grant EA, Goate AM. Failure to replicate a protective effect of allele 2 of NACP/alpha-synuclein polymorphism in Alzheimer's disease: an association study. Annals of Neurology. 44: 278-81. PMID 9708555 DOI: 10.1002/Ana.410440223 |
0.373 |
|
| 1998 |
Rubin EH, Storandt M, Miller JP, Kinscherf DA, Grant EA, Morris JC, Berg L. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Archives of Neurology. 55: 395-401. PMID 9520014 DOI: 10.1001/Archneur.55.3.395 |
0.692 |
|
| 1996 |
Morris JC, Storandt M, McKeel DW, Rubin EH, Price JL, Grant EA, Berg L. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology. 46: 707-19. PMID 8618671 DOI: 10.1212/Wnl.46.3.707 |
0.717 |
|
| 1994 |
Morris J, Storandt M, McKeel D, Rubin E, Grant E. Normal aging versus very mild Alzheimer's disease: Clinicopathologic distinctions Neurobiology of Aging. 15: S140. DOI: 10.1016/0197-4580(94)93030-9 |
0.675 |
|
| 1991 |
Morris JC, McKeel DW, Storandt M, Rubin EH, Price JL, Grant EA, Ball MJ, Berg L. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology. 41: 469-78. PMID 2011242 DOI: 10.1212/Wnl.41.4.469 |
0.717 |
|
| 1991 |
Wippold FJ, Gado MH, Morris J, Duchek JM, Grant EA. Senile dementia and healthy aging: a longitudinal CT study. Radiology. 179: 215-219. PMID 2006279 DOI: 10.1148/Radiology.179.1.2006279 |
0.353 |
|
| 1991 |
Rubin EH, Kinscherf DA, Grant EA, Storandt M. The influence of major depression on clinical and psychometric assessment of senile dementia of the Alzheimer type. The American Journal of Psychiatry. 148: 1164-71. PMID 1882993 DOI: 10.1176/Ajp.148.9.1164 |
0.682 |
|
| 1990 |
Davis PB, Morris JC, Grant E. Brief screening tests versus clinical staging in senile dementia of the Alzheimer type. Journal of the American Geriatrics Society. 38: 129-35. PMID 2299116 DOI: 10.1111/J.1532-5415.1990.Tb03473.X |
0.472 |
|
| 1989 |
McCulla MM, Coats M, Van Fleet N, Duchek J, Grant E, Morris JC. Reliability of clinical nurse specialists in the staging of dementia. Archives of Neurology. 46: 1210-1. PMID 2818255 DOI: 10.1001/Archneur.1989.00520470070029 |
0.378 |
|
| 1989 |
Morris JC, Drazner M, Fulling K, Grant EA, Goldring J. Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors? Archives of Neurology. 46: 651-7. PMID 2730377 DOI: 10.1001/Archneur.1989.00520420071025 |
0.485 |
|
| 1989 |
Rubin EH, Morris JC, Grant EA, Vendegna T. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Archives of Neurology. 46: 379-82. PMID 2650663 DOI: 10.1001/Archneur.1989.00520400033016 |
0.556 |
|
| 1978 |
Grant EA, Storandt M, Botwinick J. Incentive and practice in the psychomotor performance of the elderly. Journal of Gerontology. 33: 413-5. PMID 748435 DOI: 10.1093/Geronj/33.3.413 |
0.671 |
|
| 1978 |
Storandt M, Grant EA, Gordon BC. Remote memory as a function of age and sex. Experimental Aging Research. 4: 365-75. PMID 738316 DOI: 10.1080/03610737808257161 |
0.541 |
|
| Show low-probability matches. |